Mar 2024

HeartForce Commences Production of 200 CardioClin’s for Testing Purposes

The manufacturing process for 200 CardioClin devices for testing purposes has commenced. HeartForce has started producing 200 units of the CardioClin version 3.0, which features a new compact and seamless design. These devices will be sent to key opinion leaders in Canada, Germany, and Switzerland. Each device will come with 20 patches and an additional battery to allow users of the prototype to conduct multiple heart tests.

The initial shipments are scheduled to start by the end of April. All devices will be delivered in both functional and visually appealing boxes that contain the CardioClin and a small case with foam inserts. Within the case, users will find 20 patches and an extra battery.

Back to News